416 related articles for article (PubMed ID: 20680649)
1. Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre.
Dammers R; Schouten JW; Haitsma IK; Vincent AJ; Kros JM; Dirven CM
Acta Neurochir (Wien); 2010 Nov; 152(11):1915-21. PubMed ID: 20680649
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting diagnostic yield in needle biopsy for brain lesions.
Tsermoulas G; Mukerji N; Borah AJ; Mitchell P; Ross N
Br J Neurosurg; 2013 Apr; 27(2):207-11. PubMed ID: 22984980
[TBL] [Abstract][Full Text] [Related]
3. Complications Following Stereotactic Needle Biopsy of Intracranial Tumors.
Malone H; Yang J; Hershman DL; Wright JD; Bruce JN; Neugut AI
World Neurosurg; 2015 Oct; 84(4):1084-9. PubMed ID: 26008141
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of frameless and frame-based intracranial biopsy techniques.
Dammers R; Haitsma IK; Schouten JW; Kros JM; Avezaat CJ; Vincent AJ
Acta Neurochir (Wien); 2008 Jan; 150(1):23-9. PubMed ID: 18172567
[TBL] [Abstract][Full Text] [Related]
5. Frame-based stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy.
Smith JS; Quiñones-Hinojosa A; Barbaro NM; McDermott MW
J Neurooncol; 2005 Jun; 73(2):173-9. PubMed ID: 15981109
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Yield of Stereotactic Brain Biopsy in a Sub-Saharan Tertiary Center: A Comprehensive 10-Year Retrospective Analysis.
Mogere EK; Abdifatah K; Maina B; Nassiuma M; Olunya DLO; Cheserem B; Qureshi M
World Neurosurg; 2024 Apr; 184():e689-e694. PubMed ID: 38346588
[TBL] [Abstract][Full Text] [Related]
7. The safety and efficacy of stereotactic biopsy for intracranial lesions.
Hall WA
Cancer; 1998 May; 82(9):1749-55. PubMed ID: 9576298
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of frame-based, frameless, and intraoperative magnetic resonance imaging-guided brain biopsy techniques.
Lu Y; Yeung C; Radmanesh A; Wiemann R; Black PM; Golby AJ
World Neurosurg; 2015 Mar; 83(3):261-8. PubMed ID: 25088233
[TBL] [Abstract][Full Text] [Related]
9. The advantages of frameless stereotactic biopsy over frame-based biopsy.
Dorward NL; Paleologos TS; Alberti O; Thomas DG
Br J Neurosurg; 2002 Apr; 16(2):110-8. PubMed ID: 12046728
[TBL] [Abstract][Full Text] [Related]
10. Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging.
Bernays RL; Kollias SS; Khan N; Brandner S; Meier S; Yonekawa Y
J Neurosurg; 2002 Aug; 97(2):354-62. PubMed ID: 12186464
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting diagnostic yield in stereotactic biopsy for brain lesions: a 5-year single-center series.
Lau BL; Vijian K; Liew DNS; Wong ASH
Neurosurg Rev; 2022 Apr; 45(2):1473-1480. PubMed ID: 34628562
[TBL] [Abstract][Full Text] [Related]
12. The safety and diagnostic value of frame-based and CT-guided stereotactic brain biopsy technique.
Ersahin M; Karaaslan N; Gurbuz MS; Hakan T; Berkman MZ; Ekinci O; Denizli N; Aker FV
Turk Neurosurg; 2011; 21(4):582-90. PubMed ID: 22194120
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis.
Dhawan S; Venteicher AS; Butler WE; Carter BS; Chen CC
J Neurooncol; 2021 Aug; 154(1):1-11. PubMed ID: 34251602
[TBL] [Abstract][Full Text] [Related]
14. Frozen section evaluation of stereotactic brain biopsies: diagnostic yield at the stereotactic target position in 188 cases.
Brainard JA; Prayson RA; Barnett GH
Arch Pathol Lab Med; 1997 May; 121(5):481-4. PubMed ID: 9167601
[TBL] [Abstract][Full Text] [Related]
15. Fluorescein-assisted stereotactic needle biopsy of brain tumors: a single-center experience and systematic review.
Catapano G; Sgulò FG; Seneca V; Iorio G; de Notaris M; di Nuzzo G
Neurosurg Rev; 2019 Jun; 42(2):309-318. PubMed ID: 29383601
[TBL] [Abstract][Full Text] [Related]
16. 5-Aminolevulinic acid-induced protoporphyrin IX fluorescence as immediate intraoperative indicator to improve the safety of malignant or high-grade brain tumor diagnosis in frameless stereotactic biopsies.
von Campe G; Moschopulos M; Hefti M
Acta Neurochir (Wien); 2012 Apr; 154(4):585-8; discussion 588. PubMed ID: 22297399
[TBL] [Abstract][Full Text] [Related]
17. Frameless image-guided stereotactic brain biopsy procedure: diagnostic yield, surgical morbidity, and comparison with the frame-based technique.
Woodworth GF; McGirt MJ; Samdani A; Garonzik I; Olivi A; Weingart JD
J Neurosurg; 2006 Feb; 104(2):233-7. PubMed ID: 16509497
[TBL] [Abstract][Full Text] [Related]
18. Complications of MRI-guided stereotactic biopsy of brain lymphoma.
Malikova H; Liscak R; Latnerova I; Guseynova K; Syrucek M; Pytlik R
Neuro Endocrinol Lett; 2014; 35(7):613-8. PubMed ID: 25617885
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy and Field for Improvement of Frameless Stereotactic Brain Biopsy: A Focus on Nondiagnostic Cases.
He Z; Zhu CXL; Chan DTM; Cheung TCY; Ng HK; Mok VCT; Poon WS
J Neurol Surg A Cent Eur Neurosurg; 2024 Jan; 85(1):48-61. PubMed ID: 36481998
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic yield of fluorescence-assisted frame-based stereotactic biopsies of intracerebral lesions in comparison with frozen-section analysis.
Malinova V; von Eckardstein K; Mielke D; Rohde V
J Neurooncol; 2020 Sep; 149(2):315-323. PubMed ID: 32852725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
